Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Ip, Touw"'
Autor:
M Ünalan, Siarhei Kandabarau, D Steinemann, Martin Stanulla, Gudrun Göhring, R Hoogenboezem, Susanne Schnittger, Brigitte Schlegelberger, Karl Welte, A Kohlmann, C. Zeidler, P Vandenberghe, R Beekman, David C. Dale, Julia Skokowa, Jean Donadieu, Maksim Klimiankou, MG Valkhof, V. Makaryan, IP Touw
Publikováno v:
Klinische Pädiatrie. 225
Publikováno v:
Blood. 87:132-140
Signal transduction from the granulocyte colony-stimulating factor receptor (G-CSF-R) occurs via multiple pathways, one of which involves activation of p21Ras and mitogen-activated protein kinase. The SH2 domain-containing proteins Shc and GRB2 have
Autor:
B Lowenberg, IP Touw
Publikováno v:
Blood. 81:281-292
Publikováno v:
Blood. 77:989-995
Tumor necrosis factor (TNF) acts as a potent enhancer of granulocyte- macrophage colony-stimulating factor (GM-CSF)- and interleukin-3 (IL-3)- induced human acute myeloid leukemia (AML) growth in vitro. We have analyzed the effects of TNF alpha on th
Publikováno v:
Blood. 75:1439-1445
Granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) control the proliferation of human acute myeloid leukemia (AML) cells in vitro. Previously, we have shown that receptors for GM-CSF and IL-3 are often coexpressed on A
Autor:
Jp, Koning, Aa, Soede-Bobok, Am, Schelen, Smith L, van Leeuwen D, VALERIA SANTINI, Bm, Burgering, Jl, Bos, Lowenberg B, Ip, Touw
Publikováno v:
Europe PubMed Central
The membrane-distal region of the cytoplasmic domain of human granulocyte colony-stimulating factor receptor (G-CSF-R) contains four conserved tyrosine residues: Y704, Y729, Y744, and Y764. Three of these (Y729, Y744, and Y764) are located in the C-t
Publikováno v:
Blood. 74:2668-2673
The binding of granulocyte colony-stimulating factor (G-CSF) to normal and human acute myeloid leukemia (AML) cells was investigated with radiolabeled recombinant human G-CSF (rhG-CSF). In all 14 cases of primary AML specific receptors for G-CSF were
Publikováno v:
Blood. 74(2)
Interleukin-3 (IL-3) and granulocyte-monocyte-colony-stimulating factor (GM-CSF) stimulate proliferation of human acute myeloid leukemia (AML) in vitro, although patterns of response among clinical cases are diverse. Whether regulatory abnormalities
Autor:
Gioacchino E; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Zhang W; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koyunlar C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Zink J; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Looper H; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Cancer Genome Editing Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Gussinklo KJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hoogenboezem R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bosch D; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bindels E; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Touw IP; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Pater E; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Cancer Genome Editing Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 580-593. Date of Electronic Publication: 2024 Jun 18.
Autor:
Zezulin AU; Department of Cell and Developmental Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Yen D; Department of Cell and Developmental Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Ye D; Department of Radiation Oncology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Howell ED; Department of Cell and Developmental Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Bresciani E; Oncogenesis and Development Section, Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA., Diemer J; Oncogenesis and Development Section, Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA., Ren JG; Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Ahmad MH; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA., Castilla LH; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA., Touw IP; Department of Hematology, Erasmus Medical College, Rotterdam 3015CN, the Netherlands., Minn AJ; Department of Radiation Oncology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Tong W; Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA., Liu PP; Oncogenesis and Development Section, Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA., Tan K; Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Division of Oncology and Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA., Yu W; Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; nancyas@upenn.edu yuw1@chop.edu.; Division of Oncology and Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA., Speck NA; Department of Cell and Developmental Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; nancyas@upenn.edu yuw1@chop.edu.
Publikováno v:
Genes & development [Genes Dev] 2023 Jul 01; Vol. 37 (13-14), pp. 605-620. Date of Electronic Publication: 2023 Aug 03.